Net Income (TTM) Chart

View Net Income (TTM) for CCCC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -101.42M
March 31, 2026 -103.80M
December 31, 2025 -104.99M
September 30, 2025 -119.08M
June 30, 2025 -111.58M
March 31, 2025 -103.28M
December 31, 2024 -105.32M
September 30, 2024 -105.50M
June 30, 2024 -107.87M
March 31, 2024 -126.07M
December 31, 2023 -132.49M
September 30, 2023 -134.92M
June 30, 2023 -139.84M
Date Value
March 31, 2023 -131.34M
December 31, 2022 -128.18M
September 30, 2022 -106.65M
June 30, 2022 -99.37M
March 31, 2022 -94.54M
December 31, 2021 -83.89M
September 30, 2021 -90.03M
June 30, 2021 -87.18M
March 31, 2021 -75.39M
December 31, 2020 -66.34M
September 30, 2020 -54.56M
June 30, 2020 -42.82M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Beam Therapeutics, Inc. -85.43M
Rallybio Corp. 45.55M
Q32 Bio, Inc. 33.79M
Arrowhead Pharmaceuticals, Inc. -272.12M
Oncolytics Biotech, Inc. -30.07M